State of Wisconsin Investment Board lowered its position in shares of MAXIMUS, Inc. (NYSE:MMS) by 19.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 208,200 shares of the health services provider’s stock after selling 49,815 shares during the period. State of Wisconsin Investment Board owned approximately 0.32% of MAXIMUS worth $14,903,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of MMS. Steward Partners Investment Advisory LLC acquired a new stake in shares of MAXIMUS during the fourth quarter worth approximately $169,000. Intl Fcstone Inc. acquired a new stake in shares of MAXIMUS during the second quarter worth approximately $201,000. Capital One National Association acquired a new stake in shares of MAXIMUS during the fourth quarter worth approximately $213,000. OLD National Bancorp IN acquired a new stake in shares of MAXIMUS during the third quarter worth approximately $246,000. Finally, Cubist Systematic Strategies LLC grew its position in shares of MAXIMUS by 16.0% during the second quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock worth $249,000 after buying an additional 546 shares in the last quarter. Institutional investors own 96.76% of the company’s stock.
A number of analysts have recently weighed in on the stock. Canaccord Genuity reissued a “buy” rating on shares of MAXIMUS in a research report on Wednesday, December 27th. Zacks Investment Research downgraded shares of MAXIMUS from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Finally, Maxim Group reissued a “hold” rating and set a $69.00 price target (up previously from $66.00) on shares of MAXIMUS in a research report on Thursday, February 8th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $66.60.
Shares of MAXIMUS, Inc. (NYSE:MMS) opened at $68.15 on Friday. MAXIMUS, Inc. has a 1 year low of $57.12 and a 1 year high of $72.71. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.57 and a current ratio of 2.57. The firm has a market cap of $4,426.71, a P/E ratio of 21.34, a PEG ratio of 2.26 and a beta of 1.21.
MAXIMUS (NYSE:MMS) last released its quarterly earnings data on Thursday, February 8th. The health services provider reported $0.78 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.01. The firm had revenue of $623.10 million during the quarter, compared to the consensus estimate of $624.36 million. MAXIMUS had a net margin of 8.99% and a return on equity of 22.93%. The firm’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.71 earnings per share. research analysts expect that MAXIMUS, Inc. will post 3.44 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 0.26%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s dividend payout ratio is presently 5.36%.
In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $71.73, for a total value of $71,730.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mark Andrekovich sold 5,000 shares of MAXIMUS stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $68.80, for a total transaction of $344,000.00. Following the completion of the transaction, the insider now directly owns 22,996 shares of the company’s stock, valued at approximately $1,582,124.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 102,650 shares of company stock valued at $7,034,142. 3.10% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/02/23/state-of-wisconsin-investment-board-has-14-90-million-stake-in-maximus-inc-mms.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.